VUNO’s AI solutions are reshaping the medical industry presenting a whole new level of experience to medical practitioners in their day-to-day workflow.

VUNO Med ®-DeepBrain™ VUNO Med-DeepBrain assists the diagnosis of neurodegenerative diseases by quantifying brain atrophy of 104 areas and small vessel disease burden.

VUNO stands as a global frontrunner in the realm of medical AI, boasting a compelling history of developing and successfully commercializing cutting-edge deep learning medical AI solutions …

View the Invisible, Know the Unknown. | Widely acclaimed as a true pioneer in AI-based medical solution technologies, VUNO offers a portfolio of solutions, including VUNO Med®-DeepBrain®.

Vuno is a village in the municipality of Himarë, Vlorë County, Albania. [1] It is situated along the road that connects the center of Himarë with the village of Dhërmi on the Albanian Riviera. …

Vuno aims to expand medical services in the healthcare sector to AI-based chronic disease platforms. The company actively participates in the medical field by analyzing a wide range of …

New Alzheimer's Therapies Necessitate Expanded MRI Analysis. Monoclonal antibodies are emerging disease-modifying therapies for Alzheimer’s disease that

SEOUL, South Korea, Oct. 23, 2023 /PRNewswire/ -- VUNO Inc., South Korean medical AI company has received 510(k) clearance from the Food and Drug Administration (FDA) for its …

Today, VUNO offers a portfolio of AI solutions, including Med-DeepBrain, the fastest and the most accurate AI-based WMH and atrophy measurement and diagnostics solution in the world.

2023年10月10日 · South Korean startup Vuno’s AI-powered brain imaging device has received the 510(k) certification from the U.S. Food and Drug Administration (FDA), signaling the …